Poster Presentations: Posters Saturday, 16 April 2016: Viral hepatitis: Hepatitis C – Clinical (therapy)
Daclatasvir plus Sofosbuvir plus Ribavirin for 12 or 16 Weeks in Treatment-Experienced Patients with HCV Genotype 3 Infection and Advanced Fibrosis or Cirrhosis